Angiotensin II, aldosterone, and anti-inflammatory lymphocytes: Interplay and therapeutic opportunities

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Kasal, Daniel Arthur B ^a   Schiffrin, Ernesto L ^b  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPLERENONE; ETANERCEPT; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLMESARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADAPTIVE IMMUNITY; ARTERIAL PRESSURE; CD4+ T LYMPHOCYTE; CELL GROWTH; CELL PROLIFERATION; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC POLYMORPHISM; HEMODYNAMICS; HOMEOSTASIS; HUMAN; HYPERTENSION; IMMUNE RESPONSE; LIPID PEROXIDATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; SODIUM BALANCE; T LYMPHOCYTE; WATER ABSORPTION;

EID: 84864983805     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/829786     Document Type: Review

References (40)

1. Lawes C. M., Hoorn S. V., Rodgers A., Global burden of blood-pressure-related disease, 2001. The Lancet 2008 371 9623 1513 1518 2-s2.0-43049097195 10.1016/S0140-6736(08)60655-8 (Pubitemid 351626187)
2. Brown L. M., Essential hypertension. National Medical Association 1929 21 1 1 4
3. Londres G., Hipertensão Arterial 1945 235 Rio de Janeiro, Brazil Livraria Agir Editora
4. Tigerstedt R., Bergman P. G., Niere und kerislauf. Skandinavisches Archiv für Physiologie 1898 8 223 271
5. White F. N., Grollman A., Autoimmune factors associated with infarction of the kidney. Nephron 1964 204 93 102 2-s2.0-0042417593
6. Rodríguez-Iturbe B., Pons H., Quiroz Y., Gordon K., Rincón J., Chávez M., Parra G., Herrera-Acosta J., Gómez-Garre D., Largo R., Egido J., Johnson R. J., Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney International 2001 59 6 2222 2232 2-s2.0-0035010673 10.1046/j.1523-1755.2001.0590062222.x (Pubitemid 32467615)
7. Virdis A., Schiffrin E. L., Vascular inflammation: a role in vascular disease in hypertension? Current Opinion in Nephrology and Hypertension 2003 12 2 181 187 2-s2.0-0037336589 10.1097/00041552-200303000-00009 (Pubitemid 36288319)
8. de Ciuceis C., Amiri F., Brassard P., Endemann D. H., Touyz R. M., Schiffrin E. L., Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 10 2106 2113 2-s2.0-26244446955 10.1161/01.ATV.0000181743. 28028.57 (Pubitemid 41416308)
9. Wenzel P., Knorr M., Kossmann S., Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 2011 124 12 1370 1381
10. Shao J., Nangaku M., Miyata T., Inagi R., Yamada K., Kurokawa K., Fujita T., Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003 42 1 31 38 2-s2.0-0038480717 10.1161/01.HYP.0000075082.06183.4E (Pubitemid 36842233)
11. Guzik T. J., Hoch N. E., Brown K. A., McCann L. A., Rahman A., Dikalov S., Goronzy J., Weyand C., Harrison D. G., Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. Journal of Experimental Medicine 2007 204 10 2449 2460 2-s2.0-34948825774 10.1084/jem.20070657 (Pubitemid 47529329)
12. Nataraj C., Oliverio M. I., Mannon R. B., Mannon P. J., Audoly L. P., Amuchastegui C. S., Ruiz P., Smithies O., Coffman T. M., Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. Journal of Clinical Investigation 1999 104 12 1693 1701 2-s2.0-0033369510 (Pubitemid 30053186)
13. Jurewicz M., McDermott D. H., Sechler J. M., Tinckam K., Takakura A., Carpenter C. B., Milford E., Abdi R., Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. Journal of the American Society of Nephrology 2007 18 4 1093 1102 2-s2.0-34047212750 10.1681/ASN.2006070707 (Pubitemid 46536895)
14. Hoch N. E., Guzik T. J., Chen W., Deans T., Maalouf S. A., Gratze P., Weyand C., Harrison D. G., Regulation of T-cell function by endogenously produced angiotensin II. American Journal of Physiology 2009 296 2 R208 R216 2-s2.0-61949197524 10.1152/ajpregu.90521.2008
15. Marvar P. J., Thabet S. R., Guzik T. J., Lob H. E., McCann L. A., Weyand C., Gordon F. J., Harrison D. G., Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circulation Research 2010 107 2 263 270 2-s2.0-77955171998 10.1161/CIRCRESAHA.110.217299
16. Fiebeler A., Schmidt F., Müller D. N., Park J. K., Dechend R., Bieringer M., Shagdarsuren E., Breu V., Haller H., Luft F. C., Mineralocorticoid receptor affects AP-1 and nuclear factor- κ B activation in angiotensin II-induced cardiac injury. Hypertension 2001 37 2 787 793 2-s2.0-0035090207 (Pubitemid 32199067)
17. Rocha R., Rudolph A. E., Frierdich G. E., Nachowiak D. A., Kekec B. K., Blomme E. A. G., McMahon E. G., Delyani J. A., Aldosterone induces a vascular inflammatory phenotype in the rat heart. American Journal of Physiology 2002 283 5 H1802 H1810 2-s2.0-0036838616 (Pubitemid 35217013)
18. Neves M. F., Amiri F., Virdis A., Diep Q. N., Schiffrin E. L., Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Canadian Journal of Physiology and Pharmacology 2005 83 11 999 1006 2-s2.0-33644895071 10.1139/y05-068 (Pubitemid 43385544)
19. Virdis A., Neves M. F., Amiri F., Viel E., Touyz R. M., Schiffrin E. L., Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002 40 4 504 510 2-s2.0-0036791717 10.1161/01.HYP. 0000034738.79310.06
20. Jaffe I. Z., Mendelsohn M. E., Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circulation Research 2005 96 6 643 650 2-s2.0-16444375794 10.1161/01.RES.0000159937.05502.d1 (Pubitemid 40478331)
21. Rickard A. J., Young M. J., Corticosteroid receptors, macrophages and cardiovascular disease. Journal of Molecular Endocrinology 2009 42 6 449 459 2-s2.0-67649452539 10.1677/JME-08-0144
22. Leibovitz E., Ebrahimian T., Paradis P., Schiffrin E. L., Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. Journal of Hypertension 2009 27 11 2192 2200 2-s2.0-73249125832 10.1097/HJH.0b013e328330a963
23. Wang X. L., Rainwater D. L., VandeBerg J. F., Mitchell B. D., Mahaney M. C., Genetic contributions to plasma total antioxidant activity. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 7 1190 1195 2-s2.0-0035720549 (Pubitemid 34215149)
24. Taniyama Y., Griendling K. K., Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003 42 6 1075 1081 2-s2.0-0348109425 10.1161/01.HYP.0000100443.09293.4F (Pubitemid 37549058)
25. Sedeek M., Hébert R. L., Kennedy C. R., Burns K. D., Touyz R. M., Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Current Opinion in Nephrology and Hypertension 2009 18 2 122 127 2-s2.0-63849160230 10.1097/MNH.0b013e32832923c3
26. Lee E. Y., Shim M. S., Kim M. J., Hong S. Y., Shin Y. G., Chung C. H., Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes. Experimental and Molecular Medicine 2004 36 1 65 70 2-s2.0-1642358301 (Pubitemid 38374726)
27. Brown N. J., Aldosterone and vascular inflammation. Hypertension 2008 51 2 161 167 2-s2.0-38549092093 10.1161/HYPERTENSIONAHA.107.095489 (Pubitemid 351159920)
28. Kelly D. J., Cox A. J., Gow R. M., Zhang Y., Kemp B. E., Gilbert R. E., Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 2004 44 2 195 202 2-s2.0-3543041837 10.1161/01.HYP.0000132883.20764.12 (Pubitemid 39014239)
29. Akdis C. A., Akdis M., Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. Journal of Allergy and Clinical Immunology 2009 123 4 735 746 2-s2.0-63449090874 10.1016/j.jaci.2009.02.030
30. Hall B. M., Jelbart M. E., Gurley K. E., Dorsch S. E., Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. Journal of Experimental Medicine 1985 162 5 1683 1694 2-s2.0-0022394410 (Pubitemid 16195367)
31. Powell B. R., Buist N. R. M., Stenzel P., An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. Journal of Pediatrics 1982 100 5 731 737 2-s2.0-0020038580 (Pubitemid 12155977)
32. Valencia X., Lipsky P. E., CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nature Clinical Practice Rheumatology 2007 3 11 619 626 2-s2.0-35649015342 10.1038/ncprheum0624 (Pubitemid 350031751)
33. Rodriguez-Galan M. C., Bream J. H., Farr A., Young H. A., Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression. Journal of Immunology 2005 174 5 2796 2804 2-s2.0-14044276321 (Pubitemid 40279696)
34. + regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nature Immunology 2007 8 12 1353 1362 2-s2.0-36248976097 10.1038/ni1536 (Pubitemid 350131172)
35. Belkaid Y., Regulatory T cells and infection: a dangerous necessity. Nature Reviews Immunology 2007 7 11 875 888 2-s2.0-34748873441 10.1038/nri2189 (Pubitemid 350006238)
36. + T cells. Blood 2007 109 5 2058 2065 2-s2.0-33847376532 10.1182/blood-2006-04-016451 (Pubitemid 46348206)
37. Barhoumi T., Kasal D. A., Li M. W., Shbat L., Laurant P., Neves M. F., Paradis P., Schiffrin E. L., T Regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011 57 3 469 476 2-s2.0-79953250615 10.1161/HYPERTENSIONAHA.110.162941
38. Kasal D. A., Li M. W., Shbat L., Laurant P., Neves M. F., Paradis P., Schiffrin E. L., Barhoumi T., T Regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011 57 3 469 476 2-s2.0-79953250615 10.1161/HYPERTENSIONAHA.110.162941
39. Al-Daghri N. M., Al-Attas O. S., Alokail M. S., Alkharfy K. M., Shaik N. A., Draz H. M., Bamakhramah A., Sabico S. L. B., Gender-specific associations between insulin resistance, hypertension, and markers of inflammation among adult Saudis with and without diabetes mellitus type 2. Advances in Medical Sciences 2010 55 2 179 185 2-s2.0-78650431144 10.2478/v10039-010-0052-1
40. Cheung B. M. Y., Ong K. L., Tso A. W. K., Leung R. Y. H., Xu A., Cherny S. S., Sham P. C., Lam T. H., Lam K. S. L., C-reactive protein as a predictor of hypertension in the Hong Kong cardiovascular risk factor prevalence study (CRISPS) cohort. Journal of Human Hypertension 2011 26 2 108 116 2-s2.0-78951485338 10.1038/jhh.2010.125